申请人:Threshold Pharmaceuticals, Inc.
公开号:US20130303778A1
公开(公告)日:2013-11-14
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
磷酰胺烷基化剂前药可单独或与一个或多个
抗肿瘤药物联合使用以治疗癌症。